Epigenetic regulation of glucocorticoid receptor expression in aorta from mice with hyperhomocysteinemia

Epigenetics

Volumn 7, Issue 5, 2012, Pages 514-521

  Sulistyoningrum, Dian C ^a   Singh, Ranji ^a   Devlin, Angela M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aorta; DNA methylation; Glucocorticoid receptor; Homocysteine; Nr3c1; Nrf1

Indexed keywords

BISULFITE; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GLUCOCORTICOID RECEPTOR; HOMOCYSTEINE; MESSENGER RNA; METHIONINE; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR SP1;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BINDING SITE; C57BL 6 MOUSE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIET; DNA METHYLATION; EPIGENETICS; EXON; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC REGULATION; HETEROZYGOSITY; HETEROZYGOTE; HYPERHOMOCYSTEINEMIA; MOUSE; NONHUMAN; NR3C1 GENE; PROMOTER REGION; PROTEIN EXPRESSION; PYROSEQUENCING;

MUS;

EID: 84860580429     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.19836     Document Type: Article

References (51)

1. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a metaanalysis. JAMA 2002; 288:2015-22; PMID:12387654; http://dx.doi.org/10.1001/jama.288.16.2015.
2. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Bones C, Newcombe RG, et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998; 98:1848-52; PMID:9799203.
3. Dayal S, Arning E, Bottiglieri T, Böger RH, Sigmund CD, Faraci FM, et al. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 2004; 35:1957-62; PMID:15178827; http://dx.doi.org/10.1161/01.STR.0000131749.81508.18.
4. Devlin AM, Arning E, Bottiglieri T, Faraci FM, Rozen R, Lentz SR. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 2004; 103:2624-9; PMID:14630804; http://dx.doi.org/10.1182/blood-2003-09-3078.
5. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor alpha, NAD(P)H oxidase and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003; 23:418-24; PMID:12615666; http://dx.doi.org/10.1161/01.ATV.0000061735.85377.40.
6. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996; 98:24-9; PMID:8690798; http://dx.doi.org/10.1172/JCI118771.
7. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001; 107:1263-73; PMID:11375416; http://dx.doi.org/10.1172/JCI11596.
8. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000; 106:483-91; PMID:10953023; http://dx.doi.org/10.1172/JCI8342.
9. Zhang R, Ma J, Xia M, Zhu H, Ling W. Mild hyperhomocysteinemia induced by feeding rats diets rich in methionine or deficient in folate promotes early atherosclerotic inflammatory processes. J Nutr 2004; 134:825-30; PMID:15051832.
10. Woo CWH, Siow YLOK. Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation. J Biol Chem 2008; 283:1282-92; PMID:18024959; http://dx.doi.org/10.1074/jbc.M707886200.
11. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 2004; 279:52961-9; PMID:15466479; http://dx.doi.org/10.1074/jbc.M406820200.
12. Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 2003; 101:3901-7; PMID:12506016; http://dx.doi.org/10.1182/blood-2002-08-2606.
13. Mikael LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res 2006; 98:564-71; PMID:16439690; http://dx.doi.org/10.1161/01.RES.0000204825.66410.0b.
14. Devlin AM, Singh R, Wade RE, Innis SM, Bottiglieri T, Lentz SR. Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J Biol Chem 2007; 282:37082-90; PMID:17971455; http://dx.doi.org/10.1074/jbc.M704256200.
15. Wilson KM, McCaw RB, Leo L, Arning E, Lhoták S, Bottiglieri T, et al. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27:233-40; PMID:17082485; http://dx.doi.org/10.1161/01.ATV.0000251607.96118.af.
16. Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood 2006; 108:2237-43; PMID:16804115; http://dx.doi.org/10.1182/blood-2006-02-005991.
17. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 2011; 123:2145-56; PMID:21576679; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.956839.
18. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54; PMID:14627790; http://dx.doi.org/10.1056/NEJMra023075.
19. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318-23; PMID:10884384; http://dx.doi.org/10.1074/jbc.M002725200.
20. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, et al. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 2001; 88:1203-9; PMID:11397788; http://dx.doi.org/10.1161/hh1101.092180.
21. Devlin AM, Bottiglieri T, Domann FE, Lentz SR. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem 2005; 280:25506-11; PMID:15899898; http://dx.doi.org/10.1074/jbc.M504815200.
22. Devlin AM, Singh R, Bottiglieri T, Innis SM, Green TJ. Hepatic acyl-coenzyme a:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia. J Nutr 2010; 140:231-7; PMID:20018805; http://dx.doi.org/10.3945/jn.109.112920.
23. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomäki S, Airenne K, Jänne J, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999; 19:2171-8; PMID:10479660; http://dx.doi.org/10.1161/01.ATV.19.9.2171.
24. Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002; 7:5-11; PMID:12083735; http://dx.doi.org/10.1191/1358863x02vm418oa.
25. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279:29147-54; PMID:15131116; http://dx.doi.org/10.1074/jbc.M403618200.
26. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43:985-91; PMID:10615426; http://dx.doi.org/10.1016/S0008-6363(99)00153-4.
27. Zhu S, Goldschmidt-Clermont PJ, Dong C. Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation 2005; 112:1353-61; PMID:16116050; http://dx.doi.org/10.1161/CIRCULATIONAHA.104.519025.
28. Chan Y, Fish JE, D'Abreo C, Lin S, Robb GB, Teichert AM, et al. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem 2004; 279:35087-100; PMID:15180995; http://dx.doi.org/10.1074/jbc.M405063200.
29. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C, et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 2005; 280:24824-38; PMID:15870070; http://dx.doi.org/10.1074/jbc.M502115200.
30. Poon M, Gertz SD, Fallon JT, Wiegman P, Berman JW, Sarembock IJ, et al. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits. Atherosclerosis 2001; 155:371-80; PMID:11254907; http://dx.doi.org/10.1016/S0021-9150(00)00605-5.
31. Asai K, Funaki C, Hayashi T, Yamada K, Naito M, Kuzuya M, et al. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1993; 13:892-9; http://dx.doi.org/10.1161/01.ATV.13.6.892.
32. Dhawan L, Liu B, Blaxall BC, Taubman MB. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability. J Biol Chem 2007; 282:10146-52; PMID:17276989; http://dx.doi.org/10.1074/jbc.M605925200.
33. Weaver ICG, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-54; PMID:15220929; http://dx.doi.org/10.1038/nn1276.
34. Weaver ICG, D'Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, et al. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 2007; 27:1756-68; PMID:17301183; http://dx.doi.org/10.1523/JNEUROSCI.4164-06.2007.
35. Turner JD, Schote AB, Macedo JA, Pelascini LPL, Muller CP. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochem Pharmacol 2006; 72:1529-37; PMID:16930562; http://dx.doi.org/10.1016/j.bcp.2006.07.005.
36. Strähle U, Schmidt A, Kelsey G, Stewart AF, Cole TJ, Schmid W, et al. At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proc Natl Acad Sci USA 1992; 89:6731-5; PMID:1495961; http://dx.doi.org/10.1073/pnas.89.15.6731.
37. Chen F, Watson CS, Gametchu B. Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells. J Cell Biochem 1999; 74:418-29; PMID:10412043; http://dx.doi.org/10.1002/(SICI)1097-4644(19990901)74:3418::AID-JCB103.0.CO;2-6.
38. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, et al. pigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12:342-8; PMID:19234457; http://dx.doi.org/10.1038/nn.2270.
39. Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH, et al. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008; 102:933-41; PMID:18309099; http://dx.doi.org/10.1161/CIRCRESAHA.108.171082.
40. Poon M, Megyesi J, Green RS, Zhang H, Rollins BJ, Safirstein R, et al. In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J Biol Chem 1991; 266:22375-9; PMID:1939262.
41. Coll B, Alonso-Villaverde C, Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta 2007; 383:21-9; PMID:17521622; http://dx.doi.org/10.1016/j.cca.2007.04.019.
42. Zeng X, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 2003; 93:311-20; PMID:12881478; http://dx.doi.org/10.1161/01.RES.0000087642.01082.E4.
43. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001; 103:2717-23; PMID:11390343.
44. Harrington MA, Jones PA, Imagawa M, Karin M. Cytosine methylation does not affect binding of transcription factor Sp1. Proc Natl Acad Sci USA 1988; 85:2066-70; PMID:3281160; http://dx.doi.org/10.1073/pnas.85.7.2066.
45. Leung L, Kwong M, Hou S, Lee C, Chan JY. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 2003; 278:48021-9; PMID:12968018; http://dx.doi.org/10.1074/jbc.M308439200.
46. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, et al. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995; 92:1585-9; PMID:7878023; http://dx.doi.org/10.1073/pnas.92.5.1585.
47. Friesen RW, Novak EM, Hasman D, Innis SM. Relationship of dimethylglycine, choline and betaine with oxoproline in plasma of pregnant women and their newborn infants. J Nutr 2007; 137:2641-6; PMID:18029477.
48. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262.
49. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427-31; PMID:12424112; http://dx.doi.org/10.1093/bioinformatics/18.11.1427.
50. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12:996-1006; PMID:12045153.
51. Dupont JM, Tost J, Jammes H, Gut IG. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 333:119-27; PMID:15351288; http://dx.doi.org/10.1016/j.ab.2004.05.007.